Pharmacodynamic and Predictive Biomarker Results from the Phase I Dose Escalation Study of NGM707, an ILT2/ILT4 Dual Antagonist Antibody, in Patients with Advanced Solid Tumors
Cancer Research(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Cancer Research(2024)